ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Dec 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2016-12-13

Reporting Person: Anzalone Christopher Richard (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-13	Common Stock	F	300444	$1.27	Disposed	816789	Direct

Footnotes

F1: This disposition reflects the payment of tax liability by withholding shares incident to the vesting of restricted stock units previously granted.